The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Sahin, YILMAZ; Unluhizarci, KÜRŞAD; Yılmazsoy, Ayşe; Yıkılmaz, Ali; Aygen, Ercan; Kelestimur, Fahrettin

doi:10.1111/j.1365-2265.2007.02985.x

The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Sahin Y. , Unluhizarci K. , Yılmazsoy A. , Yıkılmaz A. , Aygen E., Kelestimur F.

CLINICAL ENDOCRINOLOGY, vol.67, no.6, pp.904-908, 2007 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 67 Issue: 6
Publication Date: 2007
Doi Number: 10.1111/j.1365-2265.2007.02985.x
Title of Journal : CLINICAL ENDOCRINOLOGY
Page Numbers: pp.904-908

Abstract

Objective There are conflicting data regarding the effects of metformin in lean women with polycystic ovary syndrome (PCOS). Thus, our aim was to evaluate the effects of 6 months of metformin therapy on various metabolic and cardiovascular risk factors in lean women with PCOS.